The launch of Revvity, Inc. in May 2023 signaled the rebranding of an 85-year-old company with a dedicated focus on the diagnostics and life sciences sector. Bolstered through strategic acquisitions ...
WALTHAM, Mass.--(BUSINESS WIRE)--Today, in collaboration with single cell genomics company, Honeycomb Biotechnologies (“Honeycomb”), Revvity (NYSE: RVTY) announced the launch of a suite of new ...
Cell painting has established itself as a powerful tool for high content imaging, able to generate vast quantities of data in response to chemical perturbations. Over the past decade, cell painting ...
To rev up its cell therapy engine, AstraZeneca is looking to the aptly named Revvity. The Big Pharma has inked a licensing deal with Revvity—the new moniker for the life sciences and diagnostics ...
In this interview, Jordi Carreras delves into the fascinating world of Cell Painting, a powerful technology gaining momentum in drug discovery. He shares insights into his groundbreaking research, the ...
The HIVE CLX Single-Cell RNAseq Solution integrates sample storage and single cell profiling into a robust, instrument-free workflow Studies in innate immunology, infectious diseases and clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results